These nationwide webinars aim to share information about cancer research and its results conducted in various regions and foster collaboration and discussion for the benefit of cancer patients throughout Finland.
Welcome to the next FICAN science webinar on Wednesday 26.11. at 15-16. These national webinars are open to everyone, and aim to provide current information on high-end cancer research and its results, as well as the newest developments and best practices from different areas of Finland.
FICAN Science Webinars are nationwide events that provide a platform for sharing new scientific findings, highlighting recent advances in cancer research, and fostering collaboration between cancer researchers and clinicians across Finland. The webinar is open for all interested in cancer research.
These nationwide webinars aim to share information about cancer research and its results conducted in various regions and foster collaboration and discussion for the benefit of cancer patients throughout Finland.
The program will highlight state-of-the-art methods for studying cancer biology: advanced in vitro techniques, cutting-edge in vivo approaches, and spatial and single-cell technologies in both genomics and proteomics. In addition, the program will address computational and AI-assisted methods that are integral to cancer research.
Welcome to join the next FICAN science webinar ”Single-cell spatial tumor ecosystems in ovarian cancer” with Adjunct professor Anniina Färkkilä on 15.9. at 15.00.
The next FCI symposium will be organized in Tampere on October 1-2, 2026 in collaboration with the Tampere University, Pirha, iCAN, and FICAN.
Welcome to join the upcoming webinar, Finnish Biobanks Supporting Cancer Research, to explore how biobank data and samples are driving discoveries, supporting biomarker research, and helping integrate AI, genomics, and digital pathology into healthcare. The speakers will share insights from national initiatives and cutting-edge research projects that are shaping the future of cancer diagnosis, treatment, and personalized medicine.
